Trials / Completed
CompletedNCT00042250
IUdR/BUdR Cell Cycle Labelling
Cell Cycle Kinetics in Vivo in Patients With Hematologic Malignancies Studied by Iododeoxyuridine and Bromodeoxyuridine Labelling
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine cell cycle parameters and changes after treatment, the labelling agent is given and a bone marrow aspiration is accomplished before treatment and after treatment for comparison. Participants must be undergoing concurrent therapy for hematologic malignancy.
Detailed description
Cell cycle parameters include LI, Ts, Tc, T dpot, changes in these parameters, and differences between normal and leukemic cells in patients with hematologic malignancy prior to and following treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chemotherapy for hematologic malignancy |
Timeline
- Start date
- 1992-05-01
- Primary completion
- 2002-10-01
- Completion
- 2002-10-01
- First posted
- 2002-07-26
- Last updated
- 2012-01-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00042250. Inclusion in this directory is not an endorsement.